Concentrations and effects of zopiclone are greatly reduced by rifampicin
Open accessThe DOI matches its Crossref record.
Abstract
Aims The effects of rifampicin on the pharmacokinetics and pharmacodynamics of zopiclone, a non‐benzodiazepine hypnotic, were studied. Methods In a randomized, placebo‐controlled cross‐over study with two phases, eight young healthy volunteers took either 600 mg rifampicin or placebo once daily for 5 days. On the 6th day, 10 mg zopiclone was administered orally. Plasma zopiclone concentrations and effects of zopiclone were measured for 10 h. Results The total area under the plasma zopiclone concentration‐time curve after rifampicin was 18.0% (95% CI 13.5–22.5%) of that after placebo (86.1±34.5 ng ml−1 h vs 473±114 ng ml−1 h (mean±s.d.); P<0.001). Rifampicin decreased the peak plasma concentration of zopiclone from 76.9±27.2 ng ml−1 to 22.5±6.0 ng ml−1 (P<0.001) and the half‐life from 3.8±0.6 h to 2.3±0.9 h (P<0.005). A significant (P<0.02) reduction in the effects of zopiclone was seen in three of the five psychomotor tests used (digit symbol substitution test, critical flicker fusion test and Maddox wing test) after rifampicin pretreatment. Conclusions The strong interaction of rifampicin with zopiclone is due to enhanced metabolism of zopiclone. Zopiclone may show a reduced hypnotic effect when used concomitantly with rifampicin or other potent inducers of CYP3A4 such as phenytoin and carbamazepine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Pharmacokinetic Interactions with Rifampicin: Clinical Relevance
Niemi, M., Backman, J. T., Fromm, M. F., Neuvonen, P. J., & Kivist??, K. T. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342090-00003 · Cited by 764
Self-citationMechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
Zhou, S., Yung Chan, S., Cher Goh, B., Chan, E., Duan, W., Huang, M., & McLeod, H. L. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544030-00005 · Cited by 517
CYP induction-mediated drug interactions: in vitro assessment and clinical implications
Lin, J. H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0277-7 · Cited by 264
Noble, S., Langtry, H. D., & Lamb, H. M. (1998) · Drugs · doi:10.2165/00003495-199855020-00015 · Cited by 254
Metadata
- Authors
- Villikka, K., Kivistö, K. T., Lamberg, T. S., Kantola, T., & Neuvonen, P. J.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1997-05
- Volume
- 43
- Issue
- 5
- Pages
- 471-474
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2015613515
- Cited by
- 39
- References
- 0
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Concentrations and effects of zopiclone are greatly reduced by rifampicin. https://app.cochat.ai/papers/10.1046/j.1365-2125.1997.00579.x
- The paper
- Villikka, K., Kivistö, K. T., Lamberg, T. S., Kantola, T., & Neuvonen, P. J. (1997). Concentrations and effects of zopiclone are greatly reduced by rifampicin. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1997.00579.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.